Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells

Glycoconjugate Journal

Volumn 34, Issue 6, 2017, Pages 749-756

  Itokazu, Yutaka ^a,b   Tsai, Yi Tzang ^a,b   Yu, Robert K ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain development; DNA methylation; Epigenetics; Ganglioside; Glycosyltransferase; Histone acetylation; Neural stem cell; Neuronal differentiation; Neuronal progenitor cell

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE SYNTHASE; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; INOSITOL TETRAKISPHOSPHATE; LAMIN B; MESSENGER RNA; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE I; N ACETYLGLUCOSAMINE; NUCLEOPORIN; SIALIDASE; SYNTHETASE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ACETYLATION; B4GALNT1 GENE; BRAIN DEVELOPMENT; CELL FATE; CELL RENEWAL; CELLULAR DISTRIBUTION; DNA METHYLATION; ENDOCYTOSIS; ENZYME ACTIVITY; EPIGENETICS; GA2 SYNTHASE GENE; GALNACT GENE; GANGLIOSIDE SYNTHASE GENE; GD2 SYNTHASE GENE; GENE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC REGULATION; GM1 GENE; GM2 SYNTHASE GENE; GNT IX GENE; GT2 SYNTHASE GENE; HISTONE ACETYLATION; HUMAN; LIPID RAFT; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROD1 GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; ST II GENE; TISSUE DISTRIBUTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT;

ANIMALS; EPIGENESIS, GENETIC; GANGLIOSIDES; HISTONE CODE; HUMANS; NEURAL STEM CELLS; NEUROGENESIS;

EID: 84982311348     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-016-9719-6     Document Type: Review

References (52)

1. Yu R.K., Macala L.J., Taki T., Weinfield H.M., Yu F.S.: Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50(6), 1825–1829 (1988)
2. Yu R.K., Itokazu Y.: Glycolipid and glycoprotein expression during neural development. Advances in neurobiology. 9, 185–222 (2014). doi:10.1007/978-1-4939-1154-7_9
3. Yu R.K., Tsai Y.T., Ariga T., Yanagisawa M.: Structures, biosynthesis, and functions of gangliosides--an overview. Journal of oleo science. 60(10), 537–544 (2011)
4. Nakatani Y., Yanagisawa M., Suzuki Y., Yu R.K.: Characterization of GD3 ganglioside as a novel biomarker of mouse neural stem cells. Glycobiology. 20(1), 78–86 (2010). doi:10.1093/glycob/cwp149
5. Wang J., Yu R.K.: Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc. Natl. Acad. Sci. U. S. A. 110(47), 19137–19142 (2013). doi:10.1073/pnas.1307224110
6. Furukawa K., Ohmi Y., Ohkawa Y., Tajima O., Furukawa K.: Glycosphingolipids in the regulation of the nervous system. Advances in neurobiology. 9, 307–320 (2014). doi:10.1007/978-1-4939-1154-7_14
7. Wang J., Cheng A., Wakade C., Yu R.K.: Ganglioside GD3 is required for neurogenesis and long-term maintenance of neural stem cells in the postnatal mouse brain. The journal of neuroscience: the official journal of the society for. Neuroscience. 34(41), 13790–13800 (2014). doi:10.1523/JNEUROSCI.2275-14.2014
8. Ledeen R.W., Wu G.: The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem. Sci. 40(7), 407–418 (2015). doi:10.1016/j.tibs.2015.04.005
9. Tsai Y.T., Yu R.K.: Epigenetic activation of mouse ganglioside synthase genes: implications for neurogenesis. J. Neurochem. 128(1), 101–110 (2014). doi:10.1111/jnc.12456
10. Hirabayashi Y., Gotoh Y.: Epigenetic control of neural precursor cell fate during development. Nat Rev Neurosci. 11(6), 377–388 (2010). doi:10.1038/nrn2810
11. Jobe E.M., McQuate A.L., Zhao X.: Crosstalk among Epigenetic Pathways Regulates Neurogenesis. Frontiers in neuroscience. 6, 59 (2012). doi:10.3389/fnins.2012.00059
12. Hsieh J., Gage F.H.: Epigenetic control of neural stem cell fate. Curr Opin Genet Dev. 14(5), 461–469 (2004). doi:10.1016/j.gde.2004.07.006
13. Mehler M.F.: Epigenetics and the nervous system. Ann. Neurol. 64(6), 602–617 (2008). doi:10.1002/ana.21595
14. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H.: Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 101(47), 16659–16664 (2004). doi:10.1073/pnas.0407643101
15. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 325(5942), 834–840 (2009). doi:10.1126/science.1175371
16. Jamaladdin S., Kelly R.D., O'Regan L., Dovey O.M., Hodson G.E., Millard C.J., Portolano N., Fry A.M., Schwabe J.W., Cowley S.M.: Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 111(27), 9840–9845 (2014). doi:10.1073/pnas.1321330111
17. Watson P.J., Fairall L., Santos G.M., Schwabe J.W.: Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature. 481(7381), 335–340 (2012). doi:10.1038/nature10728
18. Millard C.J., Watson P.J., Celardo I., Gordiyenko Y., Cowley S.M., Robinson C.V., Fairall L., Schwabe J.W.: Class I HDACs share a common mechanism of regulation by inositol phosphates. Mol. Cell. 51(1), 57–67 (2013). doi:10.1016/j.molcel.2013.05.020
19. Ozcan S., Andrali S.S., Cantrell J.E.: Modulation of transcription factor function by O-GlcNAc modification. Biochim. Biophys. Acta. 1799(5–6), 353–364 (2010). doi:10.1016/j.bbagrm.2010.02.005
20. Hardiville S., Hart G.W.: Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20(2), 208–213 (2014). doi:10.1016/j.cmet.2014.07.014
21. Lewis B.A., Hanover J.A.: O-GlcNAc and the epigenetic regulation of gene expression. The Journal of biological chemistry. 289(50), 34440–34448 (2014). doi:10.1074/jbc.R114.595439
22. Suzuki Y., Yanagisawa M., Ariga T., Yu R.K.: Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development. J. Neurochem. 116(5), 874–880 (2011). doi:10.1111/j.1471-4159.2010.07042.x
23. Tsai Y.T., Itokazu Y., Yu R.K.: GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells. Neurochemical research. 41(1–2), 107–115 (2016). doi:10.1007/s11064-015-1742-7
24. Bouvier J.D., Seyfried T.N.: Ganglioside composition of normal and mutant mouse embryos. J. Neurochem. 52(2), 460–466 (1989)
25. Ngamukote S., Yanagisawa M., Ariga T., Ando S., Yu R.K.: Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J. Neurochem. 103(6), 2327–2341 (2007). doi:10.1111/j.1471-4159.2007.04910.x
26. Kizuka Y., Kitazume S., Okahara K., Villagra A., Sotomayor E.M., Taniguchi N.: Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. The Journal of biological chemistry. 289(16), 11253–11261 (2014). doi:10.1074/jbc.M114.554311
27. Kizuka Y., Kitazume S., Yoshida M., Taniguchi N.: Brain-specific expression of N-acetylglucosaminyltransferase IX (GnT-IX) is regulated by epigenetic histone modifications. The Journal of biological chemistry. 286(36), 31875–31884 (2011). doi:10.1074/jbc.M111.251173
28. Xia T., Gao L., Yu R.K., Zeng G.: Characterization of the promoter and the transcription factors for the mouse UDP-gal:betaGlcNAc beta1,3-galactosyltransferase gene. Gene. 309(2), 117–123 (2003)
29. Xia T., Zeng G., Gao L., Yu R.K.: Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene. Gene. 351, 109–118 (2005). doi:10.1016/j.gene.2005.03.010
30. Yu R.K., Bieberich E., Xia T., Zeng G.: Regulation of ganglioside biosynthesis in the nervous system. Journal of lipid research. 45(5), 783–793 (2004). doi:10.1194/jlr.R300020-JLR200
31. Takashima S., Kono M., Kurosawa N., Yoshida Y., Tachida Y., Inoue M., Kanematsu T., Tsuji S.: Genomic organization and transcriptional regulation of the mouse GD3 synthase gene (ST8Sia I): comparison of genomic organization of the mouse sialyltransferase genes. Journal of biochemistry. 128(6), 1033–1043 (2000)
32. Lucki N.C., Sewer M.B.: Nuclear sphingolipid metabolism. Annu Rev Physiol. 74, 131–151 (2012). doi:10.1146/annurev-physiol-020911-153321
33. Wang J., Wu G., Miyagi T., Lu Z.H., Ledeen R.W.: Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a. J. Neurochem. 111(2), 547–554 (2009). doi:10.1111/j.1471-4159.2009.06339.x
34. Saito M., Sugiyama K.: Characterization of nuclear gangliosides in rat brain: concentration, composition, and developmental changes. Arch. Biochem. Biophys. 398(2), 153–159 (2002). doi:10.1006/abbi.2001.2725
35. Tempera I., Buchetti B., Lococo E., Gradini R., Mastronardi A., Mascellino M.T., Sale P., Mosca L., d'Erme M., Lenti L.: GD3 nuclear localization after apoptosis induction in HUT-78 cells. Biochem. Biophys. Res. Commun. 368(3), 495–500 (2008). doi:10.1016/j.bbrc.2007.12.196
36. Hait N.C., Allegood J., Maceyka M., Strub G.M., Harikumar K.B., Singh S.K., Luo C., Marmorstein R., Kordula T., Milstien S., Spiegel S.: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science. 325(5945), 1254–1257 (2009). doi:10.1126/science.1176709
37. Talamas J.A., Capelson M.: Nuclear envelope and genome interactions in cell fate. Front. Genet. 6, 95 (2015). doi:10.3389/fgene.2015.00095
38. Wu G., Lu Z.H., Ledeen R.W.: GM1 ganglioside in the nuclear membrane modulates nuclear calcium homeostasis during neurite outgrowth. J. Neurochem. 65(3), 1419–1422 (1995)
39. Wu G., Lu Z.H., Ledeen R.W.: Induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. The Journal of neuroscience: the official journal of the Society for Neuroscience. 15(5 Pt 2), 3739–3746 (1995)
40. Xie X., Wu G., Lu Z.H., Ledeen R.W.: Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J. Neurochem. 81(6), 1185–1195 (2002)
41. Kotzerke J., Stibane C., Dralle H., Wiese H., Burchert W.: Screening for pheochromocytoma in the MEN 2 syndrome. Henry Ford Hosp Med J. 37(3–4), 129–131 (1989)
42. Saito M., Hagita H., Ito M., Ando S., Yu R.K.: Age-dependent reduction in sialidase activity of nuclear membranes from mouse brain. Exp. Gerontol. 37(7), 937–941 (2002)
43. Saito M., Fronda C.L., Yu R.K.: Sialidase activity in nuclear membranes of rat brain. J. Neurochem. 66(5), 2205–2208 (1996)
44. Ariga T., Itokazu Y., McDonald M.P., Hirabayashi Y., Ando S., Yu R.K.: Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aalpha. ASN Neuro. 5(2), 141–148 (2013). doi:10.1042/AN20130006
45. Ariga, T., Wakade, C., Yu, R.K.: The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis. Int. J. Alzheimers Dis. 2011, 193618 (2011). doi:10.4061/2011/193618
46. Itokazu Y., Yu R.K.: Amyloid beta-peptide 1-42 modulates the proliferation of mouse neural stem cells: Upregulation of Fucosyltransferase IX and notch signaling. Mol. Neurobiol. (2014). doi:10.1007/s12035-014-8634-8
47. Wu G., Lu Z.H., Kulkarni N., Ledeen R.W.: Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans. J. Neurosci. Res. 90(10), 1997–2008 (2012). doi:10.1002/jnr.23090
48. Maglione V., Marchi P., Di Pardo A., Lingrell S., Horkey M., Tidmarsh E., Sipione S.: Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1. The journal of neuroscience: the official journal of the society for. Neuroscience. 30(11), 4072–4080 (2010). doi:10.1523/JNEUROSCI.6348-09.2010
49. Rapport M.M.: Implications of altered brain ganglioside profiles in amyotrophic lateral sclerosis ALS. Acta Neurobiol. Exp. (Wars). 50(4–5), 505–513 (1990)
50. Rapport M.M., Donnenfeld H., Brunner W., Hungund B., Bartfeld H.: Ganglioside patterns in amyotrophic lateral sclerosis brain regions. Ann. Neurol. 18(1), 60–67 (1985). doi:10.1002/ana.410180111
51. Yu R.K., Ledeen R.W., Eng L.F.: Ganglioside abnormalities in multiple sclerosis. J. Neurochem. 23(1), 169–174 (1974)
52. Yu R.K., Ueno K., Glaser G.H., Tourtellotte W.W.: Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39(2), 464–477 (1982)